News Archive

MHRA - Drug Safety Update: monthly PDF newsletter

1st March 2023

Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor, the Commission on Human Medicines

Read More+

MHRA - Impact of extension of Medical Device Regulations transitional period and the validity of certificates in the EU

1st March 2023

The European Parliament has voted to adopt an extension of the transition period for the EU Medical Device Regulations and to extend the validity of certain device certificates

Read More+

MHRA - MHRA Board Meeting held in public

1st March 2023

Date: Tuesday 21 March 2023/Location: Webinar

Read More+

Meeting highlights from the CVMP 14-16 February 2023

1st March 2023

14-16 February 2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 2023

Read More+

HRA - #makeitpublic Week

27th February 2023

HRA's Make it Public strategy signals an ambition to transform research transparency in the UK.

Read More+

HRA Blog - Patients need access to industry clinical trials

27th February 2023

In October 2022, the Association for the British Pharmaceutical Industry reported that the number of clinical trials run by pharmaceutical companies in the UK had declined over recent years. In October 2022, the Association for the British Pharmaceutical Industry reported that the number of clinical trials run by pharmaceutical companies in the UK had declined over recent years. This wasn’t a case of industry just complaining about how hard it is to run their business. More importantly, they explained the impact this is having on the NHS and all of us as patients. And it’s not good news.

Read More+

EMA - Human Medicines Highlights 2022

21st February 2023

EMA releases highlights from 2022.

Read More+

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC)

15th February 2023

6 - 9 February 2023

Read More+

EMA - A new role for EMA in monitoring and mitigating critical medical device shortages during public health emergencies

15th February 2023

As of 2 February 2023, EMA’s additional responsibilities regarding the monitoring and mitigation of shortages of critical medical devices during public health emergencies will apply. The new provisions are the last remaining part to be implemented of Regulation (EU) 2022/123, that reinforces EMA’s role in crisis management of critical medicinal products and medical devices during public health emergencies.

Read More+

EMA - Actions to support the development of medicines for children

15th February 2023

Regulators in the European Union (EU) have taken several initiatives in the past four years to increase the efficiency of paediatric regulatory processes and boost the development of medicines for children.

Read More+